Table 3: Effect of the different sulfonylurea derivatives on ΔHbA1c with respect to TCF7L2 genotypes.

Entire group ( )CC ( )CT ( )TT ( )

ΔHbA1c (%) 0.0640.022a
Dominant modelCC ( )CT + TT ( )
ΔHbA1c (%) 0.0190.006
Group 1 ( )CC ( )CT ( )TT ( )
HbA1c (%) 0.0100.013b
 Dominant modelCC ( )CT + TT ( )
HbA1c (%) 0.0030.005
Group 2 ( )CC ( )CT ( )TT ( )
HbA1c (%) 0.7750.810
 Dominant modelCC ( )CT + TT ( )
HbA1c (%) 0.7920.783

value for ANOVA, value adjusted in general linear models for age, gender, baseline HbA1c, baseline BMI, and sulfonylurea dose. Post hoc comparisons between genotype groups: aCC versus CT, , CC versus TT, ; bCC versus CT, , CC versus TT, .